Pine Bridge Investments, L.P. Myriad Genetics Inc Transaction History

Pine Bridge Investments, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$9.78 - $29.53 $359,982 - $1.09 Million	-36,808 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$20.93 - $35.1 $585,684 - $982,203	-27,983 Reduced 43.19%	36,808 $1 Million
Q3 2019 Nov 13, 2019	BUY	$22.08 - $47.08 $122,831 - $261,906	5,563 Added 9.39%	64,791 $1.86 Million
Q2 2019 Aug 13, 2019	BUY	$22.67 - $35.0 $176,826 - $273,000	7,800 Added 15.17%	59,228 $1.65 Million
Q1 2019 May 14, 2019	BUY	$26.93 - $34.7 $900,162 - $1.16 Million	33,426 Added 185.68%	51,428 $1.71 Million
Q4 2018 Feb 13, 2019	BUY	$27.23 - $45.56 $94,433 - $158,002	3,468 Added 23.86%	18,002 $524,000
Q3 2018 Nov 13, 2018	BUY	$37.57 - $50.34 $112,409 - $150,617	2,992 Added 25.92%	14,534 $668,000
Q2 2018 Aug 09, 2018	SELL	$27.75 - $40.17 $16,206 - $23,459	-584 Reduced 4.82%	11,542 $432,000
Q1 2018 May 14, 2018	SELL	$28.83 - $41.01 $2.66 Million - $3.78 Million	-92,157 Reduced 88.37%	12,126 $358,000
Q4 2017 Feb 09, 2018	BUY	$28.45 - $37.14 $304,841 - $397,955	10,715 Added 11.45%	104,283 $3.58 Million
Q3 2017 Nov 13, 2017	BUY	$24.01 - $36.2 $600 - $905	25 Added 0.03%	93,568 $3.39 Million
Q2 2017 Aug 11, 2017	BUY	N/A	93,543	93,543 $2.42 Million

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

Stay updated on Pine Bridge Investments, L.P. with notifications on news.